Intralesional Quadrivalent Human Papilloma Virus Vaccine Antigen Injection in the Treatment of Genital Warts: Clinical Evaluation and Effect on Serum and Tissue Interferon Gamma.

The article focuses on several dermatological studies assessing novel treatments and biomarkers in skin-related conditions. One study found that serum levels of brain-derived neurotrophic factor (BDNF) were significantly lower in vitiligo patients compared to healthy controls, with 76% of vitiligo cases exhibiting depressive symptoms, indicating a link between BDNF, psychiatric comorbidities, and quality of life in vitiligo. Another study evaluated the clinical efficacy of intralesional quadrivalent human papillomavirus (HPV) vaccine (Gardasil) injections in treating genital warts, demonstrating a significant reduction in lesion number and size alongside changes in interferon-gamma levels. Additionally, a comparative study on postmenopausal vulvovaginal atrophy showed that both non-crosslinked hyaluronic acid and autologous platelet-rich plasma injections were effective and safe, with hyaluronic acid yielding greater improvements in sexual function and partner satisfaction. These findings highlight emerging therapeutic approaches and biomarkers relevant to dermatological and gynecological conditions.